FMA
KITE

FNY Managed Accounts’s Kite Pharma, Inc. KITE Stock Holding History

FNY Managed Accounts’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-3,412
Closed -$2.64M – 940
2017
Q3 		$2.64M Buy
+3,412
New +$475K 3.45% 2
2016
Q4 		– Sell
-12
Closed -$385 – 382
2016
Q3 		$385 Buy
+12
New +$669 ﹤0.01% 412

FNY Managed Accounts's KITE Position: Q2 2017 in Review

FNY Managed Accounts sold out of Kite Pharma, Inc. (KITE) in Q2 2017, closing a stake of 180 shares — an estimated $14K sold.

FNY Managed Accounts first reported a position in KITE in Q1 2017 and held it in 1 quarter. The position peaked at $14K in Q1 2017. 220 funds tracked by Wall St. Rank hold KITE as of Q2 2017.

  • FNY Managed Accounts reported no remaining Kite Pharma, Inc. position as of Q2 2017 after selling out during the quarter.
  • FNY Managed Accounts sold 180 Kite Pharma, Inc. shares in Q2 2017, an estimated $14K.
  • FNY Managed Accounts first reported a position in Kite Pharma, Inc. in Q1 2017 and held it in 1 quarter.
  • FNY Managed Accounts's Kite Pharma, Inc. position peaked at $14K in Q1 2017.
  • 220 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q2 2017.

Based on FNY Managed Accounts's 13F filing for Q2 2017, filed 10 Aug 2017.